PetMed Express Inc. (PETS)
PETS trades on Nasdaq in Consumer Staples, Retail-Drug Stores and Proprietary Stores. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/1040130/000104013026000019/0001040130-26-000019-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-03-31.
Profile
| Field | Value |
|---|---|
| Ticker | PETS on Nasdaq |
| Sector | Consumer Staples |
| Industry | Retail-Drug Stores and Proprietary Stores |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001040130 |
| SEC industry code | Retail-Drug Stores and Proprietary Stores |
| Incorporated in | FL |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $179.0M |
| Net income | -$57.3M |
| Operating income | -$58.7M |
| Net margin | -32.0% |
| Operating margin | -32.8% |
| Revenue growth | -21.1% |
| Cash | $21.4M |
| Total assets | $81.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "During the six months ended September 30, 2026 , management's assessment identified certain conditions and events that, when considered in the aggregate, raised substantial doubt about the Company's ability to continue as a going concern." | 10-Q 2026-11-10 |
| Cash and burn | $11.4M cash; operating cash flow -$5.7M a quarter. | Report 2026-09-30 |
| Shares outstanding | 22,231,281 (2026-11-06); 21,369,521 a year earlier; 21,147,006 three years earlier. | Cover page 2026-11-06 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Baker Tilly US, LLP, Los Angeles, California, United States; changed auditors 2 times in 24 months | 8-K 4.01 2025-12-29 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $44K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2027 2026-09-30 | $35.8M | -$6.4M | -$1.1M | $11.4M | No debt tags | $160.3M | 10-Q 2026-11-10 |
| Q1 2027 2026-06-30 | $41.0M | -$6.1M | -$7.7M | $13.1M | No debt tags | $168.9M | 10-Q 2026-08-13 |
| Q4 2026 2026-03-31 | $42.8M | -$4.1M | -$4.7M | $21.4M | No debt tags | $179.0M | 10-K 2026-06-02 |
| Q3 2026 2025-12-31 | $40.7M | -$10.6M | -$9.2M | $26.9M | No debt tags | $187.0M | 10-Q 2026-02-05 |
| Q2 2026 2025-09-30 | $44.4M | -$8.5M | -$2.2M | $36.1M | No debt tags | $198.3M | 10-Q 2026-11-10 |
| Q1 2026 2025-06-30 | $51.2M | -$34.2M | -$12.3M | $41.1M | No debt tags | $211.9M | 10-Q 2026-08-13 |
| Q4 2025 2025-03-31 | $50.8M | -$11.6M | $7.0M | $54.7M | No debt tags | $227.0M | 10-K 2026-06-02 |
| Q3 2025 2024-12-31 | $52.0M | -$707K | -$1.2M | $50.1M | No debt tags | $241.3M | 10-Q 2026-02-05 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B3 | 424B3 | 2022-06-24 |
| Latest annual report | 10-K | 2026-06-02 |
| Latest quarterly / interim | 10-Q | 2026-11-10 |
| Latest current report | 8-K | 2026-11-10 |
| Latest proxy | DEFA14A | 2026-06-25 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -23.0% |
| 1 month | -26.0% |
| 3 months | -53.7% |
| Year to date | -70.6% |
| 1 year | -52.0% |
| From 52-week high | -75.9% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Retail-Drug Stores and Proprietary Stores
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| YI | 111 Inc. | $2.84 | -0.35% | $25.0M |
| RDGT | Ridgetech Inc. | $1.01 | -4.72% | $3.7M |
| GRDN | Guardian Pharmacy Services Inc. | $49.43 | -0.18% | $3.1B |
| CVS | CVS Health Corporation | $88.59 | -0.85% | $113.3B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier